• About
    • About Sutro
    • Patient Resources
    • Collaborations
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • Diversity, Equity, Inclusion and Belonging
      • DEIB Newsletter
    • Internships
    • Sutroites
    • Volunteer Opportunities
  • Contact Us

21st Annual Needham Virtual Healthcare Conference – Presentation

Events, News, Presentations

21st Annual Needham Virtual Healthcare Conference – Presentation Download...

Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022

Events, News, Presentations, Press Releases

Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022 SOUTH SAN FRANCISCO, Calif., April 8, 2022 – Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development...

American Association for Cancer Research (AACR) Annual Meeting 2022 – Presentation

Events, News, Presentations

American Association for Cancer Research (AACR) Annual Meeting 2022 – Presentation Anti-FolRα ADC STRO-002 Induces Immunogenic Cell Death (ICD) to Enhance Anti-Tumor Activity  Download Here Audio Presentation...

Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference

Events, News, Presentations, Press Releases

Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., April 5, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company...

Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC

Events, News, Presentations, Press Releases

Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC SOUTH SAN FRANCISCO, Calif., March 30, 2022– Sutro Biopharma, Inc. (“Sutro” or the “Company”) (NASDAQ: STRO), a clinical-stage drug...

12th Annual World ADC London 2022 – Presentations

Events, News, Presentations

12th Annual World ADC London 2022 – Presentations World ADC 2022 presentation titled, “A New Molecular Class to target Tumor Immunity by both disrupting the tumor and enabling the immune system” presented by  Trevor Hallam, Ph.D., President of Scientific and Chief...
« Older Entries

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080
Phone: 650-881-6500
Fax: 650-553-9659

Google Map

Tweets by @sutrobio

Contact Us

General Inquires:
general@sutrobio.com
Business Inquires:
busdev@sutrobio.com
Investor Relations Inquires:
IR@sutrobio.com
Careers:
jobs@sutrobio.com

© 2022 Sutro Biopharma, Inc. – Privacy Policy
  • Follow
  • Follow
  • Follow